Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis

In this study, we investigated a consanguineous family in whom normal-weight individuals had hepatic steatosis and cirrhosis. Using whole-exome sequencing we found two rare homozygous variants in the glucagon receptor (GCGR) gene that cosegregated with the phenotype. In cells, the GCGR mutations result in a loss of function and increased lipid accumulation. These results highlight the potential risks associated with GCGR antagonists and the benefits of GCGR agonists, currently in clinical trials.

Authors

Institutions

Publication Details

Journal
Diabetes
Published
2025-08-25
DOI
https://doi.org/10.2337/db25-0209
Citations
4
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
8.03

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis

I. Sadaf Farooqi, Katherine Lawler, Rebecca Bounds, Edmund Godfrey et al.
4 citations
Diabetes
Pancreatic function and diabetes
8.03
article

Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis

I. Sadaf Farooqi, Katherine Lawler, Rebecca Bounds, Edmund Godfrey, Adam Duckworth, Alastair Baker, D. J. Harman, Miriam Smith, Edson Mendes de Oliveira, Matthew Hoare, S. Tamir Rashid, Elana Henning, Julia M. Keogh, Laura Watson, Kevin M. Méndez-Acevedo, Adam Syanda, Tessa Cacciottolo, Benedict C. Jones, Daniyal Ashraf
article en
4 citations

Abstract

In this study, we investigated a consanguineous family in whom normal-weight individuals had hepatic steatosis and cirrhosis. Using whole-exome sequencing we found two rare homozygous variants in the glucagon receptor (GCGR) gene that cosegregated with the phenotype. In cells, the GCGR mutations result in a loss of function and increased lipid accumulation. These results highlight the potential risks associated with GCGR antagonists and the benefits of GCGR agonists, currently in clinical trials.

DiabetesVol. 74(10)
Royal Berkshire NHS Foundation Trust (GB), Cambridge University Hospitals NHS Foundation Trust (GB), National Institute for Health and Care Research (GB), Cancer Research UK Cambridge Center (GB), Hutchison/MRC Research Centre (GB), King's College Hospital (GB), Imperial College London (GB)
Eli Lilly and Company, Wellcome Trust, Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, Diabetes UK, Fondation Leducq, Novo Nordisk, Fondation Botnar, Medical Research Council, NIHR Cambridge Biomedical Research Centre
Openalex Percentile: Top 2%
Pancreatic function and diabetes
8.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.